Tatva Chintan Pharma Chem Limi (TATVA)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 114.36 96.67 84.21 98.27 105.46 83.49 85.90 107.86 116.86 123.52 131.33 134.14
YOY Revenue Growth % 16.07% 7.3% -30.18% -21.08% -7.78% -13.63% 2.01% 9.77% 10.81% 47.94% 52.9% 24.36%
Other Income 1.02 0.76 1.21 4.53 1.17 0.38 0.04 0.72 1.16 1.01 1.73 -0.35
Total Income 115.38 97.43 85.42 102.79 106.64 83.87 85.94 108.59 118.02 124.52 133.07 133.80
Total Expenses + 82.19 85.47 77.63 84.59 77.37 74.47 82.34 106.56 108.92 110.86 115.41 117.21
Cost of Materials Consumed 47.22 46.37 41.76 43.41 41.52 39.29 45.04 47.92 63.89 61.99 69.61 67.26
Employee Benefit Expense 11.56 14.07 14.77 14.37 12.70 12.94 13.23 14.05 14.09 14.95 16.82 17.07
Other Expenses 23.41 25.04 21.10 26.81 23.16 22.24 24.07 27.18 27.10 31.49 33.88 32.76
Operating Profit 32.17 11.20 6.57 13.68 28.09 9.02 3.56 1.31 7.95 12.66 15.92 16.94
OPM % 28.1% 11.6% 7.8% 13.9% 26.6% 10.8% 4.1% 1.2% 6.8% 10.2% 12.1% 12.6%
Profit Before Tax + 13.42 11.21 5.24 13.69 6.81 -1.02 -0.24 2.03 9.10 13.66 17.66 16.59
Tax Expense 3.92 3.43 1.79 4.08 1.60 -0.36 -0.37 1.00 2.45 3.75 2.49 6.27
Tax % 29.2% 30.6% 34.1% 29.8% 23.5% - - 49.2% 26.9% 27.4% 14.1% 37.8%
Profit After Tax 9.50 7.78 3.46 9.61 5.21 -0.66 0.14 1.03 6.65 9.92 15.17 10.32
EPS (Basic) 4.29 3.43 1.48 4.11 2.23 -0.29 0.06 0.44 2.84 4.24 6.49 4.41

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
Revenue from Operations 382.71 393.50 423.61 433.65
YOY Revenue Growth % -2.74% -7.11% -2.31% -
Other Income 2.32 7.51 5.74 8.89
Total Income 385.03 401.01 429.36 442.54
Total Expenses + 377.45 329.89 352.75 385.26
Cost of Materials Consumed 173.76 178.76 215.82 254.49
Employee Benefit Expense 52.92 54.76 38.60 30.81
Other Expenses 96.64 96.37 98.33 99.96
Operating Profit 5.26 63.62 70.87 48.38
OPM % 1.4% 16.2% 16.7% 11.2%
Profit Before Exceptional 7.58 43.57 48.37 104.12
Exceptional Items 0.00 0.00 -3.59 0.00
Profit Before Tax + 7.58 43.57 44.78 104.12
Tax Expense 1.87 13.21 -0.71 8.25
Tax % 24.6% 30.3% -1.6% 7.9%
Profit After Tax 5.71 30.35 45.49 95.87
EPS (Basic) 2.44 13.26 20.52 44.59

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
ASSETS
Non-Current Assets + 571.00 520.81 442.75 0.00
Property, Plant & Equipment 525.55 426.54 195.77 0.00
Capital Work in Progress 21.54 72.93 230.74 0.00
Non-Current Investments 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00
Other Intangible Assets 3.12 0.35 0.48 0.00
Current Assets + 265.25 297.91 313.56 0.00
Inventories 133.95 152.77 162.50 0.00
Trade Receivables 82.53 69.85 84.40 0.00
Cash and Cash Equivalents 11.37 35.30 27.37 0.00
Current Investments 0.00 10.05 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00
Equity Share Capital 23.39 23.39 22.17 0.00
Other Equity 715.43 713.69 492.63 0.00
Non-Current Liabilities 1.40 1.97 5.38 0.00
Current Liabilities 96.03 79.66 236.13 0.00
Total Liabilities 97.43 81.64 241.51 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
Cash from Operating Activities 24.67 98.04 27.78 20.38
Cash from Investing Activities -65.25 -120.54 -101.14 -196.81
Cash from Financing Activities 16.57 30.52 37.80 234.96
Net Increase/Decrease in Cash -23.93 7.94 -35.65 58.54